General

10 Best AI Tools for Medical Affairs Teams

Medical affairs software and AI for MSL, insights, KOL, literature and medical information teams: 10 tools by job, compliance, a 30-day pilot and FAQ.

Mar 20263 min readGeneral

Choosing a tool? Off-the-shelf AI rarely sees your CRM, hub, specialty pharmacy and claims data. We build custom AI tools for pharma and life sciences teams that do.

Medical affairs software and AI: the short answer

Medical affairs software is not one product. It is a set of systems that each do a different job: a field medical CRM where MSLs log interactions and insights, a KOL and HCP intelligence tool, an insight analytics layer, literature and congress monitoring, a medical information system for inbound questions, and publication planning. AI now sits inside most of them, mainly to turn free text into structured themes, to search and summarise literature, and to draft responses that a person then reviews.

Most medical affairs teams do not need every category on day one. The right first purchase depends on where the work is stuck: insights that never leave MSL notes, a KOL list built by hand each launch, medical information requests answered from a shared inbox, or a publication plan living in a spreadsheet.

This guide is for medical affairs leaders, MSL managers and medical information and insights teams. It groups ten products by job, covers the compliance realities, and ends with a 30-day pilot, when to build on your own data, and what to expect from a medical affairs analytics partner.

What medical affairs software does: seven jobs

  • Field medical CRM and insight capture

    Where MSLs plan, log interactions and record insights. Everything downstream depends on what lands here.

  • KOL and HCP identification

    Finding the experts who matter in a therapy area, including rising experts.

  • Insight analytics

    Turning free-text insights into themes leadership can act on.

  • Literature and congress monitoring

    Keeping up with publications, trial readouts, congress data and competitors.

  • Medical information and inquiry handling

    Answering HCP and patient questions with approved content, and routing adverse events.

  • Publication planning

    Planning, reviewing and tracking manuscripts, abstracts and posters.

  • Generative AI drafting with review

    Drafts of summaries, letters and reports that a qualified person checks.

Field medical CRM and MSL software

  • Veeva Vault CRM (Medical)

    Veeva's CRM for field medical teams. Its medical page describes a Voice feature that records and transcribes an MSL's notes after an HCP or KOL interaction and moves the insights into the CRM, an Insight Quality feature that checks captured insights against preset benchmarks, and a Media feature for finding and sharing approved scientific content.

    • Best for teams already on Veeva or migrating to Vault CRM
    • Veeva AI agents for Vault CRM (Free Text, Voice, Pre-call) became available in December 2025
    • Inquiry handling sits in a separate product, Vault MedInquiry
  • Salesforce Life Sciences Cloud

    Salesforce's industry CRM for pharma and medtech. In April 2024 IQVIA agreed to license its OCE CRM technology to Salesforce to speed up development, and Salesforce gave October 2025 as general availability for HCP engagement. Salesforce describes AI features that suggest medical information documents and draft responses for review.

    • Best for companies standardised on Salesforce
    • Confirm which medical features are generally available in your region
    • Existing IQVIA OCE customers should ask about migration paths

KOL identification and HCP mapping tools

  • Veeva Link Key People

    A database of scientific, clinical and digital experts with profiles built from publications, clinical trials, congress activity and other public sources, plus alerts when an expert's activity changes. The Link family also includes Scientific Awareness, which tracks how a medicine or therapy is discussed across scientific and digital channels.

    • Best for global KOL mapping across therapy areas
    • Coverage varies by country and therapy area, so test yours
  • H1 HCP Universe

    H1's platform of HCP and KOL profiles, including rising experts, with activity updates and AI features for targeting. H1 also sells data feeds (Medical Intelligence Streams for HCP research, organisations and patient evidence) and a Medical MDM service for cleaning and enriching HCP master data.

    • Best where KOL lists are rebuilt by hand each launch
    • Data feeds suit teams with their own warehouse

Medical insights software and insight analytics

  • Veeva Link Medical Insights

    An insights management product: field teams capture insights in CRM or a web app, AI tags free-text MSL notes and groups related insights into medical themes, and experts review the output. Veeva lists a native Vault CRM integration as planned for the second half of 2026.

    • Best for enterprise insight programmes across countries
    • Human review of AI themes is part of the design
    • Check integration timing if you are on Vault CRM
  • Within3 Launch Intelligence platform

    Within3 positions its platform for medical affairs around field insights reporting, virtual advisory boards with many engagement formats and an AI moderator assistant, congress insights before, during and after events, and collaborative publication development.

    • Best where advisory boards and expert input are a major insight source
    • Asynchronous formats suit global expert panels

Literature, congress and competitive intelligence tools

  • AlphaSense

    A market intelligence search platform. For pharma it covers clinical trial and regulatory content (ClinicalTrials.gov, FDA, EMA, PubMed), company and industry documents, and a library of expert call transcripts that came largely through its 2024 acquisition of Tegus. Generative Search answers questions with cited sources.

    • Best for competitive and landscape questions
    • Strongest on business and trial context, less on congress abstracts
  • DistillerSR

    Literature review and evidence management software. Its pharma pages describe automated screening and extraction for reviews, continuous literature monitoring with routing to expert reviewers for pharmacovigilance, and workflows for medical writers and MSLs to find evidence for manuscripts and KOL materials, with human validation of AI output.

    • Best for structured, auditable literature work
    • Shared evidence repository across HEOR and medical
    • Launched a Smart Chat interface in October 2026

Medical information and publication planning software

  • Veeva Vault MedInquiry

    Medical information case management. Requests arrive from phone, email, CRM and web, cases get an owner and service level, frequently asked questions can be detected and answered with a response package built from approved documents in the Vault medical library, and adverse event and quality complaint data can pass to Vault Safety and Vault Quality.

    • Best for medical information teams on Veeva
    • CRM status flows back so MSLs see when a case closes
  • Envision Pharma Group: iEnvision and Datavision

    Datavision is Envision's long-established publication planning and management software for planning, review, approval, submission and tracking of publications. It now runs inside iEnvision, Envision's connected medical affairs platform, which adds embedded AI with stated human accountability.

    • Best for large publication programmes
    • Veeva Publications is the main suite alternative

Generative AI in medical affairs: where it helps and where review stays

Generative AI for medical affairs is useful in a narrow set of places, and every vendor in this guide pairs it with human review. That is the right instinct, and it should be your rule too.

Where it helps today:

  • Structuring MSL notes. Turning a spoken or typed debrief into a structured insight with a topic, product, sentiment and follow-up. Veeva's Voice and Free Text agents and similar features aim at this.
  • Theming insights. Grouping hundreds of insights into themes a medical director can read in ten minutes, with links back to the originals.
  • Literature triage. Screening and summarising new publications against a defined question, with a reviewer confirming what is relevant.
  • First drafts. Drafting medical information response letters from approved standard responses, congress summaries and insight reports for a qualified person to edit.

Where it should not run unattended: anything that goes to an HCP or patient, anything that interprets data about a product's efficacy or safety, and any decision about whether a statement is promotional. A model can still invent a citation or blur an off-label nuance.

Plans move quickly. Veeva's October 2025 roadmap listed AI agents for its medical applications for August 2026; we found no release announcement when this guide was updated, so check with Veeva. Test any AI feature on your own content before it counts toward a purchase.

Compliance realities: promotional separation, review and privacy

Compliance shapes medical affairs technology as much as features do. This is not legal advice; your legal, compliance and privacy teams set the rules. These questions come up in almost every evaluation.

  • Promotional and non-promotional separation. Medical affairs exists to exchange scientific information without a promotional purpose. Many companies separate medical and commercial access in shared systems: separate record types, permission sets and reports, and rules about whether sales teams can see MSL insights at all. Check that a tool can enforce your company's version of that line, including in AI features that search across content.
  • Medical review versus MLR. Promotional material goes through medical, legal and regulatory review. Medical materials such as standard response letters and slide decks for scientific exchange follow their own review process. Any AI drafting tool should feed into that process, record who approved what, and only draw on approved content when it produces anything external.
  • Adverse events. Insight notes, inquiry intake and advisory board transcripts can all contain reportable safety information. The tool, and anyone using AI on its text, needs a route to pharmacovigilance within your required timelines.
  • Privacy. HCP data falls under privacy law in most markets, and patient information can appear in inquiries. Ask where data is stored, which models process it, whether your data is used to train them, and how long it is kept.
  • Audit trail. Expect to show who captured, edited, approved and sent each item. Most vendors here advertise audit trails; test them in the pilot.

Medical affairs software compared by job

The table summarises the products above. It is based on each vendor's own pages, read on 31 October 2026. None of these vendors publishes list prices.

ProductMain jobWhere AI shows upQuestions to test
Veeva Vault CRM (Medical)MSL CRM and insight captureVoice transcription, insight quality checks, CRM agentsTime to log an insight; quality of structured output
Salesforce Life Sciences CloudPharma CRM including medicalSuggested documents and draft responsesWhich medical features are live in your markets
Veeva Link Key PeopleKOL identificationExpert profiling and alertsCoverage of your top 100 experts
H1 HCP UniverseKOL and HCP intelligence, data feedsTargeting and profile intelligenceRising expert recall; feed quality in your warehouse
Veeva Link Medical InsightsInsight analyticsTagging and theming with expert reviewDo the themes match what your medical directors see?
Within3Advisory boards and insight reportingModerator assistant, insight reportsTurnaround from board to report
AlphaSenseCompetitive and landscape intelligenceGenerative Search with citationsAccuracy on a question you already know the answer to
DistillerSRLiterature review and monitoringScreening and extraction with human validationRecall on a literature set you have screened by hand
Veeva Vault MedInquiryMedical informationFAQ detection and response packagesTime to respond; adverse event handoff
Envision Datavision (iEnvision)Publication planningEmbedded AI with human accountabilityFit with your review and approval steps

Veeva covers almost every row through its own suite, which is the main argument for one ecosystem. The argument against is paying for depth you do not use.

How to measure the value of medical affairs technology

Medical affairs teams are often asked to prove value without sales numbers to point to. Pick measures before you buy, record a baseline, and judge the tool against it. Useful ones:

  • Insight volume and quality. Insights captured per MSL per month, and the share that meet your quality standard: specific, attributed to an HCP type, tied to a strategic question.
  • Insight to action. How many themes reached a medical plan, an evidence gap list or a publication plan in the quarter, and how long that took from first mention.
  • Time to response. For medical information, median and 90th percentile days from inquiry to response, by channel and by whether a standard response existed.
  • Coverage. Share of priority KOLs and institutions engaged in the period, and share of the expert list that was refreshed rather than carried over.
  • Literature currency. Days from publication of a relevant paper to a reviewed summary in the hands of the team.
  • Time returned to MSLs. Hours per week spent on admin before and after.

Most of these need data joined from several systems, which is where many teams find they need a reporting layer of their own.

How to choose medical affairs software

Name the bottleneck

Write down the one job that hurts most, with an example from last quarter. Buy for that first.

List the data it must touch

CRM interactions, insights, inquiry cases, KOL lists, publication plans: where each lives and who owns it.

Check fit with your CRM

If you are on Vault CRM or Salesforce, start with what your CRM vendor offers, then compare specialists on depth. Integration costs often decide the outcome.

Test AI on your own content

Ask every vendor to run their AI on a sample of your de-identified insights or literature, not on a demo set. Score the output with your own reviewers.

Walk compliance through it early

Show legal, compliance, privacy and pharmacovigilance the data flows and AI features before the shortlist is final, not after.

Ask about exports

Your insight history is a strategic asset. Confirm you can export structured data and audit trails in a usable format, including if you leave.

A 30-day pilot to run before you buy

Days 1 to 3: set the question and baseline

Pick one therapy area and one job, such as insight theming. Pull last quarter's numbers for the measures above.

Days 4 to 7: prepare a test set

Assemble 200 to 500 de-identified insight notes, or one month of literature, or 50 closed inquiries, with compliance sign-off on what can be shared.

Days 8 to 14: run it in the tool

Have the vendor configure the tool on your test set. Two or three MSLs or reviewers use it for real work, not a scripted demo.

Days 15 to 21: score blind

Your medical directors compare the tool's themes, summaries or drafts against what the team produced by hand, without knowing which is which.

Days 22 to 26: test the edges

Check permissions between medical and commercial users, the adverse event route, the audit trail and the export.

Days 27 to 30: decide with numbers

Compare against the baseline. Buy, extend the pilot or walk away, and write down why.

When a custom build on your own data beats buying

Buy the system of record: the CRM, the medical information case system, the publication planner. Validation, audit trails and vendor support are expensive to recreate.

Building often wins for the layer on top. Consider it when:

  • Your data sits in several systems. Insights in CRM, inquiries in a med info tool, advisory board output in another platform and KOL lists in spreadsheets. No single vendor dashboard shows all of it.
  • Your questions are specific. For example, which unsolicited questions from HCPs map to known evidence gaps, or how insight themes differ between academic and community experts in one indication.
  • You want AI on your terms. Theming or summarisation run inside your own cloud environment, with your taxonomy, your review step and your choice of model.
  • You are a smaller or emerging company. With one or two products and a small field medical team, an enterprise insights platform can cost more than the problem.

This is the work Greenwolf Tech Labs does. We build custom medical affairs insight dashboards and AI on a team's own CRM, insight, medical information and literature data, so the reporting matches the team's own definitions and stays alongside the systems it already uses. A typical build starts with Veeva CRM data integration or the Salesforce equivalent, lands the data in a pharma data warehouse with medical and commercial access kept apart, adds an insight theming step with human review, and ends in dashboards for medical directors and MSL managers.

Medical affairs consulting and analytics: when to bring in a partner

Medical affairs consulting ranges from strategy firms that design medical plans to agencies that run advisory boards and publications. The part that touches software is medical affairs analytics: defining measures, connecting systems and building the reports and AI on top. Bring in help when:

  • You are choosing between platforms and want an evaluation that is not run by a vendor.
  • You have the tools but leadership still asks for insight reports that take weeks to assemble by hand.
  • You are preparing for a launch and need KOL, insight and inquiry data in one view before the field team starts.
  • You are migrating CRM and want the insight history and reporting to survive the move.

What a partner should do: agree the questions and measures with you first; map where each piece of data lives; build the pipelines and the reporting layer; set up AI features with review steps and audit trails; and hand over documentation your team can run without them.

What to ask before you hire one:

  • Do you resell or receive referral fees from any software vendor you might recommend?
  • How do you keep medical and commercial data separate in what you build?
  • Where will our data be processed, and which AI models touch it?
  • What do we own at the end: code, data models, documentation?

Our guide to Komodo Health vs IQVIA applies the same test-first approach to claims data, and our pharma commercial analytics and specialty pharma analytics work covers the commercial side. For patient programmes, see AI tools for patient journey analytics and AI tools for hub services automation.

Medical affairs software and AI: common questions

What software do medical affairs teams use?
Most use a field medical CRM such as Veeva Vault CRM or Salesforce Life Sciences Cloud, a medical information system such as Veeva Vault MedInquiry, a KOL intelligence tool such as Veeva Link Key People or H1, and publication planning software such as Envision's Datavision or Veeva Publications. Larger teams add insight analytics and literature monitoring.
How is AI used in medical affairs?
Mainly to structure and theme free-text MSL insights, to screen and summarise literature, to search competitive and trial information with cited answers, and to draft medical information responses and reports. In every case a qualified person should review the output before it is used or sent.
What are the best AI tools for MSLs?
For day-to-day work, the AI inside the CRM matters most, such as voice capture that turns a debrief into a structured insight. For preparation, KOL tools like Veeva Link Key People or H1 and literature tools like DistillerSR or AlphaSense help.
Can generative AI be used for medical information responses?
It can draft responses from approved standard response documents, and some vendors offer this. The response still needs medical review under your company's process, and the system needs a route for any adverse event mentioned in the inquiry.
How do you measure medical affairs insights?
Track insights captured per MSL, the share meeting a quality standard, how many themes reached a medical plan or evidence gap list, and how long that took. Add time to response and coverage of priority experts, with a baseline recorded first.
How much does medical affairs software cost?
None of the vendors in this guide publishes list prices. Cost depends on users, modules, countries, data feeds and term length. Budget separately for integration and validation.
Should a small biotech buy a medical affairs platform or build its own reporting?
Buy the system of record you need, usually a CRM and a medical information process. For insight reporting, a small team can often get further with a custom dashboard on its own CRM and inquiry data than with an enterprise insights platform.

Want your medical affairs insights in one place?

Tell us which systems hold your CRM, insight, medical information and literature data, and the questions your medical leadership keeps asking. We will outline what a custom insight dashboard or AI step on that data would take. Please do not send any patient or HCP personal information.

Contact us

Part of our Pharma Commercial and Patient Analytics hub. Start with our specialty pharmacy analytics.

Build, not buy

Want an AI tool built around your data?

Tell us which tool on this list came closest and what it is missing. We will come back with what building the right one for pharma and life sciences teams takes.

  • Runs on your CRM, hub, specialty pharmacy and claims data
  • Built inside your own systems, not another login
  • A fixed timeline after the first call
  • A reply from a consultant, usually within one working day

We reply from [email protected], usually within one working day. We do not add you to a mailing list.